{'fraction_non_alphanumeric': 0.02531645569620253, 'fraction_numerical': 0.014466546112115732, 'mean_word_length': 4.956989247311828, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Role of Steroids in the Treatment of Diabetic Macular Edema

Macular edema is a major cause of significant visual impairments and is seen in several eye diseases, including diabetic retinopathy, uveitis, and retinal vein occlusion. Diabetic macular edema (DME) remains the predominant cause of vision impairment in people with diabetes. In the Wisconsin Epidemiological Study of Diabetic Retinopathy, DME was also found to develop in 20.1% of people with type I diabetes and 25.4% of people with insulin-dependent type II diabetes over a 10 year period.